Evaluation of Glycemic Impact on Fetal Liver Length and Volume by Ultrasound in Pregnancy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-52
SponsorAssiut University
About this trial
The primary aim of this study is to evaluate whether fetal liver length and volume, as assessed by ultrasound, can serve as reliable markers of the metabolic impact of Gestational Diabetes Mellitus (GDM) on the fetus.
Eligibility criteria
Qualifiers
gestational age 24wks-36wks by an early pregnancy ultrasound exam including CRL length
normal maternal blood sugar levels in early pregnancy
diagnosed as GDM
singleton viable pregnancy
Disqualifiers
preexisting diabetes
fetal congenital anomalies or chromosomal abnormalities
maternal chronic illnesses (e.g. Hypertension , thyroid disorders)
multiple pregnancies
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov